We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+5.05%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$56.6B
AUM Growth
+$810M
Cap. Flow
-$1.48B
Cap. Flow %
-2.61%
Top 10 Hldgs %
13.48%
Holding
2,531
New
387
Increased
823
Reduced
1,010
Closed
163

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$94.6M
2
AMAT icon
Applied Materials
AMAT
+$91.8M
3
ANET icon
Arista Networks
ANET
+$73.5M
4
ILMN icon
Illumina
ILMN
+$50.4M
5
TV icon
Televisa
TV
+$49.9M

Top Sells

Rank Stock Value
1
MRO
Marathon Oil Corporation
MRO
+$149M
2
DLTR icon
Dollar Tree
DLTR
+$140M
3
INTC icon
Intel
INTC
+$129M
4
NVDA icon
NVIDIA
NVDA
+$104M
5
NLSN
Nielsen Holdings plc
NLSN
+$84.8M

Sector Composition

Rank Sector Weight
1 Healthcare 15.88%
2 Financials 15.63%
3 Technology 12.66%
4 Energy 10.4%
5 Industrials 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NITE
2301
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$8K ﹤0.01%
+600
New +$10.8K
ONCS
2302
DELISTED
OncoSec Medical Incorporated
ONCS
$8K ﹤0.01%
+23
New +$8.06K
SGYP
2303
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$8K ﹤0.01%
+3,800
New +$9.45K
SPHS
2304
DELISTED
Sophiris Bio, Inc.
SPHS
$8K ﹤0.01%
+3,700
New +$8.05K
CYTK icon
2305
Cytokinetics
CYTK
$11B
$7K ﹤0.01%
+900
New +$10.2K
GIB icon
2306
CGI
GIB
$13.9B
$7K ﹤0.01%
134
– –
IBRX icon
2307
ImmunityBio
IBRX
$7.44B
$7K ﹤0.01%
+1,500
New +$7.1K
MUFG icon
2308
Mitsubishi UFJ Financial
MUFG
$258B
$7K ﹤0.01%
906
– –
NGNE icon
2309
Neurogene
NGNE
$696M
$7K ﹤0.01%
+30
New +$7.03K
IMDX
2310
Insight Molecular Diagnostics
IMDX
$153M
$7K ﹤0.01%
+70
New +$7.89K
PHG icon
2311
Philips
PHG
$25.4B
$7K ﹤0.01%
252
– –
TM icon
2312
Toyota
TM
$210B
$7K ﹤0.01%
58
– –
SCTL
2313
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$7K ﹤0.01%
+903
New +$7.41K
VYNT
2314
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$7K ﹤0.01%
+26
New +$9.92K
TARA icon
2315
Protara Therapeutics
TARA
$226M
$6K ﹤0.01%
+85
New +$6.82K
ACOR
2316
DELISTED
Acorda Therapeutics
ACOR
$6K ﹤0.01%
3
-5,695
-100% -$16.2M
FSBW icon
2317
FS Bancorp
FSBW
$324M
$5K ﹤0.01%
+200
New +$5.5K
HLIT icon
2318
Harmonic Inc
HLIT
$1.21B
$5K ﹤0.01%
+1,161
New +$4.36K
MBCN
2319
DELISTED
Middlefield Banc Corp
MBCN
$5K ﹤0.01%
200
-2,600
-93% -$60.4K
RHP icon
2320
Ryman Hospitality Properties
RHP
$8.4B
$5K ﹤0.01%
13,600
-400
-3% -$26.7K
ZYME icon
2321
Zymeworks
ZYME
$1.68B
$5K ﹤0.01%
+600
New +$4.93K
PRHI
2322
Presurance Holdings
PRHI
$20.1M
$4K ﹤0.01%
+100
New +$4.34K
INUV icon
2323
Inuvo
INUV
$16M
$4K ﹤0.01%
+433
New +$3.73K
LYV icon
2324
Live Nation Entertainment
LYV
$41.2B
$4K ﹤0.01%
100
-9,200
-99% -$400K
NCSM icon
2325
NCS Multistage Holdings
NCSM
$124M
$4K ﹤0.01%
+15
New +$5.55K
91 92
93
94 95

Similar funds

AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return

Macquarie Group's Q4 2017 Portfolio in Review

As of Q4 2017, Macquarie Group held 2,531 positions worth $56.6B, up 1.5% from $55.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Macquarie Group's Q4 2017 filing shows 387 new, 823 increased, 1,010 reduced and 163 closed positions. Its largest new stake was WPP: 343,817 shares worth $31.1M. The largest sale was Marathon Oil Corporation, an estimated $149M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Financials and Technology.

  • Macquarie Group's largest Q4 2017 buy was WPP: 343,817 shares worth $31.1M.
  • Macquarie Group added most to CME Group in Q4 2017, an estimated $94.6M increase.
  • Macquarie Group's biggest Q4 2017 reduction was Marathon Oil Corporation, cutting an estimated $149M.
  • Macquarie Group fully exited Alexander & Baldwin in Q4 2017, selling an estimated $30.1M.
  • Macquarie Group's ten largest holdings make up 13% of its $56.6B portfolio in Q4 2017.
  • Macquarie Group opened 387 new positions and closed 163 in Q4 2017.
  • Macquarie Group's portfolio value rose 1.5% quarter-over-quarter to $56.6B.

Based on Macquarie Group's 13F filing for Q4 2017, filed 15 Feb 2018.